Dorato Capital Management Purchases Shares of 710 McKesson Corporation $MCK

Dorato Capital Management acquired a new position in shares of McKesson Corporation (NYSE:MCK) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 710 shares of the company’s stock, valued at approximately $592,000.

A number of other institutional investors also recently made changes to their positions in MCK. GGM Financials LLC acquired a new position in shares of McKesson in the third quarter valued at approximately $25,000. State of Wyoming acquired a new stake in McKesson during the 2nd quarter worth approximately $29,000. Hopwood Financial Services Inc. acquired a new stake in McKesson during the 3rd quarter worth approximately $31,000. Board of the Pension Protection Fund bought a new stake in McKesson in the 4th quarter valued at $33,000. Finally, Vermillion & White Wealth Management Group LLC bought a new stake in McKesson in the 3rd quarter valued at $33,000. Institutional investors own 85.07% of the company’s stock.

Insider Buying and Selling

In other news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the company’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $955.00, for a total transaction of $313,240.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Thomas L. Rodgers sold 276 shares of the stock in a transaction that occurred on Monday, January 5th. The stock was sold at an average price of $816.18, for a total transaction of $225,265.68. Following the sale, the executive vice president owned 2,268 shares in the company, valued at $1,851,096.24. This represents a 10.85% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 3,868 shares of company stock worth $3,743,820. 0.08% of the stock is owned by company insiders.

McKesson Stock Performance

NYSE:MCK opened at $885.42 on Friday. The company has a market cap of $108.45 billion, a price-to-earnings ratio of 25.46, a PEG ratio of 1.24 and a beta of 0.42. McKesson Corporation has a fifty-two week low of $637.00 and a fifty-two week high of $999.00. The stock has a fifty day moving average price of $911.25 and a 200-day moving average price of $843.28.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. The company had revenue of $106.16 billion for the quarter, compared to analysts’ expectations of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.McKesson’s revenue was up 11.4% on a year-over-year basis. During the same quarter last year, the business earned $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Research analysts predict that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd were given a $0.82 dividend. The ex-dividend date was Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson’s payout ratio is presently 9.43%.

Wall Street Analysts Forecast Growth

MCK has been the topic of several recent research reports. Evercore reiterated an “outperform” rating on shares of McKesson in a research report on Thursday, March 5th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of McKesson in a research report on Wednesday, December 10th. TD Cowen raised their price target on shares of McKesson from $1,000.00 to $1,012.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. Mizuho lifted their price objective on shares of McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a research note on Thursday, February 5th. Finally, Barclays boosted their price objective on shares of McKesson from $960.00 to $1,050.00 and gave the company an “overweight” rating in a report on Wednesday, February 18th. Thirteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $960.93.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.